PHARVARIS N.V. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.79 USD | -4.24% |
|
-3.12% | -25.88% |
| 09/05 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
| 08/05 | Pharvaris N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHARVARIS N.V. | Other Biotechnology & Medical Research | -4.24% | -3.12% | -25.88% | +144.59% | - | 116.84Cr |  | |  |
- Stock Market
- Equities
- PHVS Stock
- Charts Pharvaris N.V.
- Relative Strength Chart